MX345063B - Cepas probióticas para mejorar el sistema nervioso entérico. - Google Patents

Cepas probióticas para mejorar el sistema nervioso entérico.

Info

Publication number
MX345063B
MX345063B MX2012013834A MX2012013834A MX345063B MX 345063 B MX345063 B MX 345063B MX 2012013834 A MX2012013834 A MX 2012013834A MX 2012013834 A MX2012013834 A MX 2012013834A MX 345063 B MX345063 B MX 345063B
Authority
MX
Mexico
Prior art keywords
nervous system
improving
enteric nervous
probiotic strains
enteric
Prior art date
Application number
MX2012013834A
Other languages
English (en)
Other versions
MX2012013834A (es
Inventor
Smokvina Tamara
Chambaud Isabelle
Grompone Gianfranco
Legrain-Raspaud Sophie
Capronnier Sandrine
Lesic Biliana
Degivry Marie-Christine
Neunlist Michel
Original Assignee
Cie Gervais Danone *
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cie Gervais Danone * filed Critical Cie Gervais Danone *
Publication of MX2012013834A publication Critical patent/MX2012013834A/es
Publication of MX345063B publication Critical patent/MX345063B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
    • A23C9/00—Milk preparations; Milk powder or milk powder preparations
    • A23C9/12—Fermented milk preparations; Treatment using microorganisms or enzymes
    • A23C9/123—Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt
    • A23C9/1234—Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt characterised by using a Lactobacillus sp. other than Lactobacillus Bulgaricus, including Bificlobacterium sp.
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745—Bifidobacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/10—Laxatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/11—Lactobacillus
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/51—Bifidobacterium
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/225—Lactobacillus

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Virology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Nutrition Science (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Obesity (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

La presente invención se refiere al uso de bacterias de ácido láctico para usarse en la modificación del sistema nervioso entérico y más particularmente para tratar y/o prevenir los problemas intestinales tales como constipación y/o enfermedad del intestino irritable.
MX2012013834A 2010-05-28 2011-05-27 Cepas probióticas para mejorar el sistema nervioso entérico. MX345063B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PCT/IB2010/001534 WO2011148219A1 (en) 2010-05-28 2010-05-28 Probiotic strains for use in improving the enteric nervous system
PCT/IB2011/052344 WO2011148355A1 (en) 2010-05-28 2011-05-27 Probiotic strains for use in improving the enteric nervous system

Publications (2)

Publication Number Publication Date
MX2012013834A MX2012013834A (es) 2013-04-08
MX345063B true MX345063B (es) 2017-01-16

Family

ID=43302705

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2012013834A MX345063B (es) 2010-05-28 2011-05-27 Cepas probióticas para mejorar el sistema nervioso entérico.

Country Status (14)

Country Link
US (2) US9198940B2 (es)
EP (2) EP2575837B1 (es)
JP (1) JP5923492B2 (es)
KR (1) KR101779832B1 (es)
CN (1) CN103209698B (es)
BR (1) BR112012030359B1 (es)
CA (1) CA2800768C (es)
EA (1) EA028015B1 (es)
ES (2) ES2744274T3 (es)
MX (1) MX345063B (es)
PL (1) PL2575837T3 (es)
PT (1) PT2575837E (es)
WO (2) WO2011148219A1 (es)
ZA (1) ZA201208977B (es)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2609813A1 (en) * 2011-12-30 2013-07-03 Nestec S.A. Lactobacillus reuteri DSM 17938 for the development of the enteric nervous system
UA118339C2 (uk) * 2012-09-03 2019-01-10 Біогайа Аб Бактеріальний штам lactobacillus gasseri для лікування порушення моторики кишечнику (варіанти)
JP2016507216A (ja) 2012-11-12 2016-03-10 コンパニ・ジェルベ・ダノンＣｏｍｐａｇｎｉｅ Ｇｅｒｖａｉｓ Ｄａｎｏｎｅ 体脂肪の蓄積を低減させるためのラクトバチルスラムノサス株
WO2014096901A1 (en) * 2012-12-18 2014-06-26 Compagnie Gervais Danone Strain of bifidobacterium animalis ssp. animalis
FR3004621B1 (fr) 2013-04-19 2015-05-15 Gervais Danone Sa Souche de lactobacillus rhamnosus regulatrice du metabolisme lipidique
CN103898007B (zh) * 2014-02-21 2016-08-17 刘洛贤 一株有活性的双歧杆菌菌株
JP6402016B2 (ja) * 2014-12-10 2018-10-10 国立大学法人岐阜大学 神経機能改善剤
WO2016174623A1 (en) * 2015-04-30 2016-11-03 Probiotical Healthcare S.R.L. Use of antibiotics with specific therapeutic activities combined with the simultaneous use of lactobacilli and/or bifidobacteria with a non-transferable antibiotic resistance, having the same therapeutic indication
US9730969B2 (en) 2015-11-06 2017-08-15 Mead Johnson Nutrition Company Nutritional compositions for promoting gut barrier function and ameliorating visceral pain
AU2018341753B2 (en) * 2017-09-29 2021-11-18 Navipharm Co,Ltd Novel lactic acid bacteria and use thereof
CN108753670A (zh) * 2018-05-28 2018-11-06 西北工业大学 多功能复合微生态制剂纳米硒-重组表达血管活性肠肽-乳酸乳球菌及制备方法
KR102238519B1 (ko) * 2018-12-28 2021-04-13 (주)메디톡스 외래 단백질을 발현하는 미생물, 및 그의 용도
KR102635553B1 (ko) * 2018-12-28 2024-02-13 주식회사 리비옴 외래 단백질을 발현하는 미생물, 및 그의 용도
JP2023507383A (ja) * 2019-12-17 2023-02-22 メタジェニックス，インコーポレイティド 多系統プロバイオティクス組成物およびその使用
KR20210129516A (ko) 2020-04-20 2021-10-28 주식회사 리비옴 혈관 작동성 장 펩티드를 발현하는 미생물, 및 그의 용도
KR102527954B1 (ko) * 2021-03-29 2023-05-03 주식회사 리비옴 외래 단백질을 발현하는 미생물, 및 그의 용도
CN113248520A (zh) * 2021-04-07 2021-08-13 浙江华显光电科技有限公司 一种有机化合物及使用该化合物的有机发光器件
WO2024080918A1 (en) * 2022-10-13 2024-04-18 Baylor College Of Medicine Secretin inducing bacteria

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH07173188A (ja) * 1993-12-17 1995-07-11 Tsumura & Co 新規アリソールおよびアリソール類を有効成分とする脳機能改善剤
ID29150A (id) * 1999-01-15 2001-08-02 Entpr Ireland Cs Penggunaan lactobacillus salivarius
FR2795917B1 (fr) 1999-07-06 2001-08-31 Gervais Danone Sa Procede de preparation d'un produit lacte immunostimulant et ses applications
FR2811333B1 (fr) 2000-07-04 2003-01-10 Gervais Danone Sa Microorganismes ayant une action modulatrice de la glycosylation de surface des cellules intestinales et methode de selection desdits microorganismes
PE20030284A1 (es) 2001-07-26 2003-05-01 Alimentary Health Ltd Cepas de bifidobacterium
FR2875406B1 (fr) 2004-09-21 2007-01-05 Danisco Souche de lactobacillus acidophilus ayant des proprietes analgesiques au niveau du systeme gastro-intestinal
ITMI20042189A1 (it) * 2004-11-16 2005-02-16 Anidral Srl Composizione a base di batteri probiotici e suo uso nella prevenzione e-o nel trattamento di patologie e-o infezioni respiratorie e nel miglioramento della funzionalita' intestinale
EP3067057B1 (en) 2005-09-28 2022-11-09 Nordic Rebalance A/S Probiotic fermented cereal compositions for use in treatment of gastrointestinal disorders caused by pro-inflammatory bacteria
US20090311227A1 (en) 2006-05-12 2009-12-17 Danisco A/S Composition
CN101095698B (zh) * 2006-06-26 2010-12-01 青岛东海药业有限公司 酪酸梭菌防治便臭毒素引起的相关症状和疾病的用途
WO2008064489A1 (en) 2006-12-01 2008-06-05 Mcmaster University Probiotics to inhibit inflammation
FR2921795B1 (fr) * 2007-10-03 2011-04-29 Gervais Danone Sa Utilisation d'une souche de bifidobacterium,pour la preparation d'une composition destinee a la prevention et/ou au traitement de manifestations de type allergique
ES2395838T3 (es) 2007-12-21 2013-02-15 Compagnie Gervais Danone Método para disminuir el contorno abdominal administrando una bacteria del tipo Bifidobacterium
WO2010008272A1 (en) * 2008-07-15 2010-01-21 N.V. Nutricia Treatment of gut motility disorders
ES2436620T3 (es) * 2009-11-02 2014-01-03 Compagnie Gervais Danone Método para reducir la inflamación gastro-intestinal usando la bacteria Bifidobacterium animalis o un producto lácteo fermentado que comprende dicha bacteria
WO2011148220A1 (en) * 2010-05-28 2011-12-01 Compagnie Gervais Danone Probiotic strains for use in improving transepithelial resistance

Also Published As

Publication number Publication date
EA028015B1 (ru) 2017-09-29
CA2800768A1 (en) 2011-12-01
EA201291441A1 (ru) 2013-05-30
BR112012030359B1 (pt) 2020-05-05
US20130195822A1 (en) 2013-08-01
WO2011148355A1 (en) 2011-12-01
ES2508566T3 (es) 2014-10-16
US9198940B2 (en) 2015-12-01
JP2013528053A (ja) 2013-07-08
PL2575837T3 (pl) 2015-03-31
JP5923492B2 (ja) 2016-05-24
KR101779832B1 (ko) 2017-09-19
PT2575837E (pt) 2014-10-01
KR20140000620A (ko) 2014-01-03
CN103209698B (zh) 2015-09-02
ES2744274T3 (es) 2020-02-24
EP2857027B1 (en) 2019-06-12
EP2857027A1 (en) 2015-04-08
MX2012013834A (es) 2013-04-08
CN103209698A (zh) 2013-07-17
EP2575837B1 (en) 2014-06-25
BR112012030359A2 (pt) 2016-08-09
US20160045557A1 (en) 2016-02-18
CA2800768C (en) 2020-07-21
EP2575837A1 (en) 2013-04-10
WO2011148219A1 (en) 2011-12-01
ZA201208977B (en) 2014-04-30

Similar Documents

Publication Publication Date Title
MX345063B (es) Cepas probióticas para mejorar el sistema nervioso entérico.
IN2012DN02463A (es)
IN2012DN01638A (es)
UA108198C2 (uk) Заміщені 2-ацетамідо-5-арил-1,2,4-триазолони та їх застосування
IN2012DN02737A (es)
MX2015006491A (es) Composiciones bacterianas sinergicas y metodos de produccion y uso de las mismas.
MX2011005527A (es) Uso de la bacteria de acido lactico para tratar o prevenir el eczema.
EA201490004A1 (ru) Применение bifidobacterium lactis bl-04 для лечения заболеваний дыхательных путей
MX2018009945A (es) Composiciones y metodos novedosos para el tratamiento de las enfermedades relacionadas con la inmunidad.
CA2813064C (en) Methods for treating autoimmune disease using biocompatible bioabsorbable nanospheres
NZ599561A (en) Compositions and methods for the prevention and treatment of autoimmune conditions
EP2440210A4 (en) METHOD FOR THE TREATMENT OF STOMACH DARM DISEASES
MX344786B (es) Composiciones y metodos para tratar enfermedad de gaucher.
MX2011007930A (es) Conjugados de insulina cristalina.
IN2012DN00624A (es)
IN2012DN02645A (es)
BR112012033212A2 (pt) uso de lactobacillo inibindo a produção de gás de bactéria coliforme isolada em infantes afetados por cólica
IN2012DN02471A (es)
WO2011106541A3 (en) Diagnostic methods involving loss of heterozygosity
PL2753687T3 (pl) Szczepy bakterii kwasu mlekowego i/lub bifidobakterii hamujących/zmniejszających wzrost różnych biotypów E. coli i różnych biotypów bakterii z rodzaju Clostridium
UA118339C2 (uk) Бактеріальний штам lactobacillus gasseri для лікування порушення моторики кишечнику (варіанти)
WO2009080800A3 (en) Method for decreasing abdominal girth by administering a bifidobacterium bacteria
MY158310A (en) Prevention and treatment of allergic diarrhoea
EP2490721A4 (en) COMPOSITIONS, TREATMENT PROCEDURES AND DIAGNOSIS OF AUTOIMMUN-MEDIATED ILLNESSES AND METHOD FOR THE PREPARATION OF SUCH COMPOSITIONS
MX2012013835A (es) Cepas probioticas para aumentar la resistencia transepitelial.

Legal Events

Date Code Title Description
FG Grant or registration